Plasmapheresis in the preparation of women with tubal-peritoneal infertility for an IVF program and embryo transfer into the uterine cavity
| Specialty | obstetrics and gynecology |
| Author | Anna Sergeevna Ochan |
| Number of pages | 138 |
| Organization | Moscow Regional Research Institute of Obstetrics and Gynecology |
| Work performed at | Department of Gravitational Surgery of Blood and Laboratory of Clinical Embryology of the National Medical Research Center of Obstetrics, Gynecology and Perinatology of RAMS |
| Defense (year) | 2003 |
| Supervisor | Doctor of Medical Sciences T.A. Fedorova, Doctor of Medical Sciences L.N. Kuzmichev |
| Opponents | Doctor of Medical Sciences P.A. Kiryuchenko, Doctor of Medical Sciences S.G. Tsakhilova |
Relevance of the problem
In vitro fertilization (IVF) with subsequent embryo transfer (ET) into the uterine cavity has firmly entered medical practice as a recognized method of infertility treatment. The efficiency of infertility treatment using modern reproductive technologies has reached 30–40% per attempt in the best medical centers of the world (European Society of Human Reproduction and Embryology (ESHRE), 2000). It is known from the literature that the most frequently occurring form is tubal-peritoneal infertility due to chronic inflammatory diseases of the internal genital organs (Ovsyannikova T.V., 1995; Nazarenko T.A., 1998; Korneeva I.E., 2003). Numerous studies indicate that the inflammatory process leads not only to adhesion formation, but also causes polysystem changes in the body (Davydovsky I.V., 1969; Ivanyuta L.I., 1992; Fedorova T.A., 1996; Samsonov N.N., 2002). Thus, decreased immunoresistance, circulation of pathological autoantibodies, and endointoxication exert a significant negative influence on the results of the IVF program and, subsequently, on the course of pregnancy. A special role is assigned to the increased coagulation potential of blood in this patient population, most often progressing in the form of chronic disseminated intravascular coagulation (DIC) syndrome. This is of particular significance in connection with the fact that hormonal stimulation of superovulation during the IVF program is a powerful activating factor triggering the process of pathological microthrombosis under conditions of an already existing hypercoagulable shift. The presence of undiagnosed processes of activation of intravascular coagulation (IVC) before the program is a predisposing factor for the development of complications such as ovarian hyperstimulation syndrome (OHSS), pregnancy loss, gestosis, and placental insufficiency, in the pathogenesis of which an important link is chronic DIC syndrome.
The relevance of the problem is further conditioned by the fact that at present superovulation stimulation schemes using gonadolibberin agonists and antagonists (aGn) are widely used, allowing pregnancy to be achieved in 40–50% of program cycles in women with this form of infertility (River J., 2001; Kindarova L.B., 2001; Smolnikova V.Yu., 2002; Kalinina E.A., 2002). In proportion to the increase in IVF efficiency, the risk of OHSS and pregnancy loss increases. In this connection, it is necessary to search for methods that would allow neutralizing possible causes of IVF inefficiency and reducing the risk of complications during the program and the subsequent course of pregnancy. An effective means of rehabilitation for this patient group appears to be therapeutic plasmapheresis (PP), which, thanks to its detoxifying, rheo- and immunocorrecting effects, exerts a significant influence on pathogenetic factors hindering the successful implementation of the IVF program, and will also allow substantially reducing the drug load on the body during correction of identified disorders.
In view of the above, the aim of the work was to increase the efficiency of IVF and ET in women with tubal-peritoneal infertility by conducting pre-induction preparation for the program using plasmapheresis.
To achieve the set aim, the following research objectives were formulated:
1. To identify the features of the hemostasis system state in women with tubal-peritoneal infertility and to determine their role in the structure of factors reducing the efficiency of the IVF program.
2. To study the possibilities of detecting markers of early IVC activation (platelet antiheparin factor (PF4) and the thrombin-antithrombin III complex (TAT)) for predicting hemostasiological disorders during preparation for and implementation of IVF and ET in women with tubal-peritoneal infertility.
3. To optimize the technique of performing PP during preparation for IVF and ET in women with tubal-peritoneal infertility.
4. To analyze the frequency of pregnancy, occurrence of complications, and reproductive losses during IVF and ET in the study groups.
5. To analyze the course of pregnancy and delivery outcomes in the study groups.
Scientific novelty
As a result of the study performed, the expediency of performing PP for preparation for IVF and ET was shown for the first time.
The possibilities of detecting early markers of IVC activation in patients with tubal-peritoneal infertility were studied for the first time, and their prognostic significance was determined. Using in vivo computer phasometry, the morphofunctional features of platelets in women with this form of infertility were studied, and their changes under the influence of PP were identified and evaluated.
Practical significance
As a result of the study performed, a method of preparing women with tubal-peritoneal infertility for an IVF program was developed, allowing achievement of a high pregnancy rate, substantial reduction of the risk of OHSS and reproductive losses. A number of practical recommendations on the most optimal use of this method has been implemented in practice.
The possibility of using early markers of IVC activation for hemostasiological screening of disorders during preparation for and implementation of IVF and ET was determined, which makes it possible to timely carry out therapeutic measures and monitor their effectiveness, which as a result allows increasing the efficiency of infertility treatment.
The possibility of using morphometric study of platelets with the prospect of creating an express method of diagnosing the state of the cellular link of hemostasis was justified.
Implementation of the work results
The main results of the work have been implemented in the practical activity of the Department of Gravitational Surgery of Blood and the Laboratory of Clinical Embryology of the National Medical Research Center of Obstetrics, Gynecology and Perinatology of RAMS.
Dissertation provisions put forward for defense:
1. In women with tubal-peritoneal infertility, a supercompensated form of chronic DIC syndrome is present in 70.5% of cases, manifesting as thrombinemia, increased levels of coagulation substrates and cofactors, and relative consumption thrombocytopathy as a result of chronic activation and changes in the morphofunctional properties of platelets.
2. Performing PP for the preparation of women with tubal-peritoneal infertility for IVF and ET allows normalizing the state of the hemostasis system before the program and substantially reducing the activating influence of steroid hormones on the blood coagulation system during superovulation stimulation.
3. Preparing women with tubal-peritoneal infertility for IVF and ET using PP allows increasing the efficiency and safety of the program due to a high pregnancy rate and reduced frequency of reproductive losses and OHSS.
Approval of the work
The main provisions and results of the study were presented and discussed at an interclinical conference (December 27, 2001) and a meeting of the approval commission of the National Medical Research Center of Obstetrics, Gynecology and Perinatology of RAMS (July 1, 2003).
The materials of the dissertation were presented and discussed at the X Conference of the Moscow Society of Hemapheresis (2002), at the seminar "New Technologies in Obstetrics, Gynecology, and Neonatology (Effluent and Quantum Therapy Methods)" (2002), and at the International Congress "Prevention, Diagnosis, and Treatment of Gynecological Diseases" (2003).
Structure and volume of the dissertation
The dissertation consists of an introduction, 4 chapters, conclusions and practical recommendations; it is written on 138 pages of typewritten text and includes 21 tables and 15 figures. The reference list contains 173 works, including 127 domestic and 46 works by foreign authors.
